Portage Biotech Inc (PRTG) — Cash Flow-to-Debt Ratio
Portage Biotech Inc (PRTG) has a Cash Flow-to-Debt Ratio of -0.78x as of September 2024, meaning its operating cash flow of $-1.56 Million could theoretically repay -1% of its total liabilities ($2.01 Million) in one year. Explore investment intensity of Portage Biotech Inc to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Portage Biotech Inc Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Portage Biotech Inc across 27 annual periods. Also explore Portage Biotech Inc total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Portage Biotech Inc (1998–2025)
Year-by-year debt coverage analysis for Portage Biotech Inc. For market capitalisation and broader financial context, see Portage Biotech Inc (PRTG) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.79x | $-5.46 Million | $3.05 Million | ▲ +44.3% |
| 2024 | -3.21x | $-14.30 Million | $4.45 Million | ▼ -531.6% |
| 2023 | -0.51x | $-12.07 Million | $23.73 Million | ▼ -119.8% |
| 2022 | -0.23x | $-6.76 Million | $29.23 Million | ▼ -47.2% |
| 2021 | -0.16x | $-4.28 Million | $27.26 Million | ▼ -16.5% |
| 2020 | -0.13x | $-3.71 Million | $27.53 Million | ▼ -295.5% |
| 2019 | -0.03x | $-858.00K | $25.16 Million | ▲ +98.8% |
| 2018 | -2.79x | $-1.07 Million | $384.00K | ▲ +34.6% |
| 2017 | -4.27x | $-1.32 Million | $309.43K | ▲ +78.1% |
| 2016 | -19.48x | $-5.84 Million | $299.74K | ▼ -362.5% |
| 2015 | -4.21x | $-2.61 Million | $620.56K | ▲ +58.2% |
| 2014 | -10.08x | $-1.94 Million | $191.97K | ▼ -151.5% |
| 2013 | -4.01x | $-1.79 Million | $446.87K | ▼ -696.4% |
| 2012 | -0.50x | $-1.34 Million | $2.66 Million | ▲ +86.9% |
| 2011 | -3.84x | $-2.62 Million | $682.75K | ▼ -3626.2% |
| 2010 | -0.10x | $-356.14K | $3.45 Million | ▲ +95.7% |
| 2009 | -2.39x | $-287.38K | $120.39K | ▲ +70.8% |
| 2008 | -8.18x | $-468.92K | $57.34K | ▲ +25.1% |
| 2007 | -10.93x | $-458.84K | $42.00K | ▼ -139.5% |
| 2006 | -4.56x | $-645.50K | $141.52K | ▼ -837.2% |
| 2004 | -0.49x | $-321.51K | $660.63K | ▲ +22.5% |
| 2003 | -0.63x | $-146.90K | $233.80K | ▲ +49.3% |
| 2002 | -1.24x | $-156.80K | $126.48K | ▲ +66.2% |
| 2001 | -3.67x | $-347.00K | $94.62K | ▼ -19.1% |
| 2000 | -3.08x | $-466.90K | $151.67K | ▲ +41.9% |
| 1999 | -5.30x | $-345.09K | $65.14K | ▼ -522.1% |
| 1998 | -0.85x | $-422.97K | $496.67K | — |